Is FHTX or GANX more undervalued in 2026?

CirclFi compares Foghorn Therapeutics Inc. (FHTX) and Gain Therapeutics, Inc. (GANX) using 13 institutional-grade valuation models. FHTX has a Quality of Company score of 6.3/10 while GANX scores 4.3/10.

Which is a better buy — FHTX or GANX?

Compare intrinsic values from 13 independent models against current market prices. CirclFi also calculates Value Trap scores. This is not financial advice — conduct your own analysis.

How do FHTX and GANX valuations compare?

FHTX at $4.27 and GANX at $2.02 are compared across Bayesian DCF, EPV, EROIC Spread, First Chicago, Markov DDM, and 8 additional models.

FHTX vs GANX Valuation Comparison 2026 — Intrinsic Value Analysis

FHTX

Biotechnology

Foghorn Therapeutics Inc.

Quality

6.3

out of 10

Value Trap

SAFE

Price

$4.27

Last close

Models

7/13

Active

GANX

Biotechnology

Gain Therapeutics, Inc.

Quality

4.3

out of 10

Value Trap

LOW

Price

$2.02

Last close

Models

7/13

Active

Model-by-Model Comparison

Model	Type	FHTX Fair Value	FHTX Upside	GANX Fair Value	GANX Upside
Bayesian DCF	Intrinsic	$1.34	-68.5%	$0.75	-63.0%
First Chicago	Scenario	$•••.••	••.•%	$•••.••	••.•%
ML-RIV	Intrinsic	$0.53	-87.6%	$0.47	-76.7%
Dynamic NAV	Asset-Based	$•••.••	••.•%	$•••.••	••.•%
PWERM	Option-Based	$8.29	+94.0%	$2.01	-0.3%
Regime Cross-Sectional	Relative	$•••.••	••.•%	$•••.••	••.•%
Sentiment SOTP	Hybrid	$•••.••	••.•%	$•••.••	••.•%
CUCE Ensemble	Ensemble	$•••.••	••.•%	$•••.••	••.•%

🔒

Unlock Full 13-Model Comparison

Access all valuation models for FHTX vs GANX — including EROIC Spread, First Chicago, Markov DDM, PWERM, and 7 more.

Access Full Analysis — From $27/mo →

FHTX vs GANX — Which Stock Is More Undervalued?

FHTX scores higher with a 6.3/10 quality rating vs GANX's 4.3/10. Both stocks are analyzed daily using SEC EDGAR filings across 13 independent models.

Comparing Foghorn Therapeutics Inc. (FHTX) and Gain Therapeutics, Inc. (GANX) across 13 institutional-grade valuation models reveals how each company's intrinsic value stacks up against its market price. CirclFi's engine processes SEC EDGAR 10-K and 10-Q filings, FRED macroeconomic data, and GDELT news sentiment to generate independent fair value estimates daily.

FHTX currently trades at $4.27 with a QOC of 6.3/10, while GANX trades at $2.02 with a QOC of 4.3/10.

Both companies are analyzed with models spanning intrinsic (Bayesian DCF, EPV), scenario-based (First Chicago), regime-switching (Markov DDM, RCMH-DCF), machine learning (ML-RIV, FTNN Topology), and ensemble methods (CUCE).